BPA for xofigo and adempas
Active Awarded Last action
- Contract number
- 36E79725A0028
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 52% complete
- IDV ceiling
- $6,788,810.45
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a Blanket Purchase Agreement with Bayer Healthcare Pharmaceuticals Inc. on October 6, 2025, for Xofigo and Adempas pharmaceutical products, with a ceiling of $6,788,810.45 and ultimate completion on October 5, 2027.
The BPA is established against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple-award schedule through the Department of Veterans Affairs. The agreement incorporates 2026 Public Law pricing updates and streamlines procurement across authorized federal agencies without additional competitive solicitation. Xofigo (radium-223 dichloride) treats castration-resistant prostate cancer; Adempas (riociguat) addresses pulmonary arterial hypertension. Performance occurs primarily at Bayer's principal operations facility in Whippany, New Jersey, with secondary distribution operations at Dublin, Ohio, and at authorized federal healthcare facilities nationwide. The BPA is a single-award vehicle with no set-aside category applied. Bayer operates as sole source on many orders due to the single-source or limited-manufacturer status of both medications.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0028?
36E79725A0028 was awarded to Bayer Healthcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 6, 2025.
How much is contract 36E79725A0028 worth?
36E79725A0028's own ceiling is $6,788,810.
Who can order from contract 36E79725A0028?
36E79725A0028 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0028 under another contract?
Yes. 36E79725A0028 is a blanket purchase agreement under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79725A0028 competed?
The extent of competition for 36E79725A0028 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV